Evidence map›Paper›PMID 33160561›Full record

ArticleLancet (London, England)2020

SARS-CoV-2 seroprevalence in Spain - Authors' reply.

Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Jesús Oteo, Mayte Pérez-Olmeda, Raquel Yotti, ENE-COVID Study Group

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Marina PollánNational Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain. Electronic address: mpollan@isciii.es.
Beatriz Pérez-GómezNational Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain.
Roberto Pastor-BarriusoNational Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain.
Jesús OteoNational Centre for Microbiology, Institute of Health Carlos III, 28029 Madrid, Spain; Spanish Network for Research in Infectious Diseases, Institute of Health Carlos III, 28029 Madrid, Spain.
Mayte Pérez-OlmedaNational Centre for Microbiology, Institute of Health Carlos III, 28029 Madrid, Spain.
Raquel YottiDirectorate, Institute of Health Carlos III, 28029 Madrid, Spain.
ENE-COVID Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralBetacoronavirusCOVID-19HumansPrevalenceSARS-CoV-2Seroepidemiologic StudiesSpain

Identifiers

PMID33160561
PMCPMC7832783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.